Panel endorses antimicrobial therapy for ulcer disease.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015975:Consensus Development Conferences, NIH as Topic; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy*; D014481:United States
D000900:Anti-Bacterial Agents